Daniel Vasella Chief executive, Novartis AG | On the Hot Seat
Novartis AG , the giant Swiss drug maker, made waves in the pharmaceutical industry three years ago when it relocated its global research headquarters to Cambridge's old Necco building -- immediately becoming one of the area's largest biotech employers and an icon of Cambridge's transformation from an industrial city to a research capital. Novartis chief executive Daniel Vasella spoke with ... (Full article: 695 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
